GlaxoSmithKline (GSK)
We've worked with scientists at GSK to see how new statistical design and analysis methods can be applied to the industrial production of new drugs.
This work meant that a key process in the production of a new skin cancer drug could be completed in a third of the time.
Before submitting drugs for the approval of the US Food and Drugs Administration, GSK scientists now use Southampton's methodology to comply with mandatory quality control requirements.